Proton pump inhibitor use during chemotherapy for platinum-resistant or platinum-refractory ovarian cancer improves overall survival

Autor: Starbuck, K., Belliotti, S., Morrell, K., Etter, J.L., Kolesnikova, K., Zsiros, E., Odunsi, K., Lele, S.B., Frederick, P.J., Akers, S.N., Eng, K.H.
Zdroj: In Gynecologic Oncology June 2018 149 Supplement 1:68-68
Databáze: ScienceDirect